drugset / Trial / NCT00012467
Safety and Antifungal Activity of Recombinant Interferon-Gamma 1b (rIFN-Gamma 1b) Given With Standard Therapy in Patients With Cryptococcal Meningitis
Double-blindTreatment
Summary
The purpose of this study is to examine the antifungal activity of recombinant interferon-gamma 1b (rIFN-gamma 1b) given with standard antifungal therapy.
Timeline
- Start
- 2000-01
- Primary completion
- —
- Completion
- 2001-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Interferon gamma-1b | Protein / enzyme biologic | — | Subcutaneous |
| Background | Amphotericin B | Unknown | — | Intravenous |
| Background | Fluconazole | Small molecule | — | Oral |
| Background | Flucytosine | Small molecule | — | Oral |
| Background | Itraconazole | Small molecule | — | Oral |